Cargando…
Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation
While anti-CEA antibodies have no direct effect on CEA-positive tumors, they can be used to direct potent anti-tumor effects as an antibody-IL-2 fusion protein (immunocytokine, ICK), and at the same time reduce the toxicity of IL-2 as a single agent. Using a fusion protein of humanized anti-CEA with...
Autores principales: | Kujawski, Maciej, Sherman, Mark, Hui, Susanta, Zuro, Darren, Lee, Wen-Hui, Yazaki, Paul, Sherman, Anakim, Szpikowska, Barbara, Chea, Junie, Lasiewski, Desiree, Poku, Kofi, Li, Harry, Colcher, David, Wong, Jeffrey, Shively, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028338/ https://www.ncbi.nlm.nih.gov/pubmed/32117587 http://dx.doi.org/10.1080/2162402X.2020.1724052 |
Ejemplares similares
-
Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
por: Cha, Seung E., et al.
Publicado: (2021) -
Improved antibody-guided surgery with a near-infrared dye on a PEGylated linker for CEA-positive tumors
por: Yazaki, Paul J., et al.
Publicado: (2019) -
Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
por: Minnix, Megan, et al.
Publicado: (2020) -
Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer
por: Lwin, Thinzar M., et al.
Publicado: (2023) -
Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
por: Kujawski, Maciej, et al.
Publicado: (2019)